X-154929410-AT-ATT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000132.4(F8):c.4379dupA(p.Asn1460LysfsTer2) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000132.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- hemophilia AInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- mild hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- moderately severe hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe hemophilia AInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- symptomatic form of hemophilia A in female carriersInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| F8 | NM_000132.4 | c.4379dupA | p.Asn1460LysfsTer2 | frameshift_variant | Exon 14 of 26 | ENST00000360256.9 | NP_000123.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F8 | ENST00000360256.9 | c.4379dupA | p.Asn1460LysfsTer2 | frameshift_variant | Exon 14 of 26 | 1 | NM_000132.4 | ENSP00000353393.4 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD2 exomes AF: 0.00000556 AC: 1AN: 179894 AF XY: 0.00 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1096940Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 362568
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:3
- -
Variant summary: F8 c.4379dupA (p.Asn1460LysfsX2) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.4379dupA has been observed in individual(s) affected with Factor VIII Deficiency (Hemophilia A) (Lu_2018). These data indicate that the variant is likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 29381227). ClinVar contains an entry for this variant (Variation ID: 1333164). Based on the evidence outlined above, the variant was classified as pathogenic. -
The frameshift duplication p.N1460Kfs*2 in F8 (NM_000132.4) has been reported in multiple affected indviduals (AbdulGhafar A et al,Hwang SH et al). It has been submitted to ClinVar as PathogenicAlthough the variant is present at 0.0006% in gnomAD Exomes, it has the flag "Failed Random Forest" and may not represent the true population frequency. The p.N1460Kfs*2 variant is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation.Loss of function variants have been reported previously as disease causing. For these reasons, this variant has been classified as Likely Pathogenic -
Hereditary factor VIII deficiency disease;C5676879:Thrombophilia, X-linked, due to factor 8 defect Pathogenic:2
- -
PM2_Supporting+PVS1+PS4_Supporting+PP4 -
not provided Pathogenic:2
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also denoted as c.4372insA due to alternative nomenclature; This variant is associated with the following publications: (PMID: 1908096, 7794769, 11102988, 8054459, 10519986, 19473408, 19686262, 18388498, 35014236, 20838461, 12325022, 12871415, 9603440, 10896236, 11298607, 11843836, 11857744, 12195713, 16601827, 18403393, 19719548, 20028422, 20800587, 29381227, 18691168, 33245802, 32497951, 32897612) -
The F8 c.4379dupA; p.Asn1460LysfsTer2 variant (rs387906455), also known as p.Asn1442LysfsTer2, is reported in numerous individuals with hemophilia A (see Factor VIII database, Lu 2018). In vitro functional analyses demonstrate that individuals with this variant have factor VIII activity of <1-8%. It is reported in one allele in the Genome Aggregation Database, but is considered a low confidence variant in that database. This variant causes a frameshift by inserting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense mediated decay. Based on available information, this variant is considered to be pathogenic. References: Link to Factor VIII database: https://f8-db.eahad.org/index.php Lu Y et al. Spectrum and origin of mutations in sporadic cases of haemophilia A in China. Haemophilia. 2018 Mar;24(2):291-298. PMID: 29381227. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at